# Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

> **NCT07406126** · — · NOT_YET_RECRUITING · sponsor: **Fernando Gómez Muñoz** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Liver Metastases (CRCLM)
- Unresectable Colorectal Liver Metastases

## Interventions

- **PROCEDURE:** Yttrium-90 Radioembolization with standard systemic therapy

## Key facts

- **NCT ID:** NCT07406126
- **Lead sponsor:** Fernando Gómez Muñoz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07406126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07406126, "Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07406126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*